Izafe Group
0,326SEK -13,53%Vær den første som følger denne virksomhed
iZafe Group conducts research, development, and marketing of medical and digital security solutions for safer pharmaceutical management at home. The company's pharmaceutical robot, Dosell, is used to reduce the risk of incorrect medication and to relieve the public healthcare system. Customers are found globally. The head office is located in Stockholm.
Omsætning
730 t
EBIT %
-3.205,48 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
IZAFE B
Daglig lav / høj pris
0,324 / 0,377
SEK
Markedsværdi
81,5 mio. SEK
Aktieomsætning
294,89 t SEK
Volumen
878 t
Finanskalender
Årsrapport
09.02.2024
Delårsrapport
26.04.2024
Delårsrapport
30.08.2024
Delårsrapport
01.11.2024
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Gästrike Nord Invest AB | 16,7 % | 16,4 % |
| Stefan Wård | 9,1 % | 8,9 % |
Premium
Not activated
This content is for our Premium customers only.
ViserAlle indholdstyper